Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
CPHI South East Asia 2026 brought together more than 11,000 pharmaceutical professionals from over 70 countries at the Q...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discover...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have reported positive Phase 2a data for vortosiran, an...
Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355, also known as SP0...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Insmed has reported positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalati...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
Lynk Pharmaceuticals has dosed the first patient in a Phase II clinical trial of LNK01004 ointment for vitiligo. The tr...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administrati...
BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim have announced the launch of a new research t...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
Evogene, a leading computational chemistry company focused on the generative design of small molecules for the pharmaceu...
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative ...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
